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34 mOsm/kg. Her arterial blood gas showed: pH <7, HCO3 7.5 mmol/L, pCO2 16 mm/
Hg. Phosphorus level was unusually high, 21.3 mg/dL, with unknown etiology. There was
no history of enema or laxative use. A significant contributor of AG was lactate at 14.5,
given her history of metformin use. Urine drug screen was positive for amphetamines.
The volatile alcohol panel was positive for acetone; methanol, ethanol, ethylene glycol
and isopropyl alcohol were not detected. Continuous venovenous hemofiltration (CVVH)
was initiated. After 3 days, renal function started recovering, lactate and phosphorus
levels normalized and AG closed. The patient did not need CVVH thereafter. Two months
later, the patient was discharged to a nursing facility in a stable condition.
Discussion: Extremely elevated AG of 52 in this patient can be explained by a rise
in concentrations of organic acid anions, lactate, ketoacids, hyperphosphatemia, and
retention anions.

Explanation of the high AG: The Figure describes the calculation of AG. In this patient,
phosphate was a major contributor to the AG.
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A Patient with Combined Metformin-Induced Lactic Acidosis and
Euglycemic Diabetic Ketoacidosis
Kamil Sardarli, Russell Leong, Inayat Gill, Sami S. Zarouk. Beaumont Health,
Royal Oak, MI.
Introduction: Metformin is a small, non-protein-bound molecule that can cause
lactic acidosis in 6 out of 100,000 patients with a mortality rate of 30-50%. Concurrent
euglycemic diabetic ketoacidosis (DKA) from sodium-glucose co-transporter-2 (SGLT2)
inhibitor has been reported in one case. We report a unique case of a patient with acute
kidney injury (AKI) in the setting of metformin-induced lactic acidosis and osmotic
diuresis due to euglycemic DKA complicated by celecoxib use.
Case Description: A 66-year-old female with a past medical history of type 2
diabetes mellitus for 21 years on metformin 1000 mg twice daily and empagliflozin 25 mg
daily with baseline eGFR 51 mL/min/1.73m2 5 months prior, who was also on celecoxib
200 mg daily for 40 days presented for elective cervical discectomy which was canceled
due to AKI. On exam, blood pressure was 119/59 mmHg, pulse was 92 beats/min, and
the temperature was 36.1°C. She was tachypneic at 24 breath/min. Labs showed sodium
136 mg/dL, potassium 8.4 mg/dL, bicarbonate 9 mg/dL, BUN 83 mg/dl, creatinine
8.78 mg/dL, and glucose 117 g/dL. Lactic acid was 13.5 mmol/L, beta-hydroxybutyrate
5.9 mmol/L, serum osmolality 336 mOsmol/kg with no osmolar gap. She underwent
conventional hemodialysis (HD) for 3 hours followed by 18 hours of continuous kidney
replacement therapy (CKRT). She required an insulin drip with 5% dextrose in normal
saline for 24 hours. Lactic acid was 3.8 mmol/L after 24 hours. Creatinine improved
to 2.46 mg/dL on day 4 without further intervention. She was discharged home off
metformin, empagliflozin, and celecoxib.
Discussion: Metformin is readily dialyzable but has a large volume of distribution.
There is no specific antidote available to reverse the toxic effects of metformin or
consensus on the modality of renal replacement therapy. Previously demonstrated
biphasic elimination pattern of metformin intoxication suggests that a brief HD session
is not sufficient to eliminate metformin due to a rebound phenomenon, but it is essential
to correct severe acidosis and electrolyte derangements. Hyperkalemia required the use
of HD which needed to be followed by CKRT as a more physiological way to maximize
metformin removal and prevent ongoing lactic acid production. We suggest prudence in
the combination of metformin with SGLT2 inhibitor use, specifically in patients exposed
to nephrotoxic drugs or procedures.
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Mind the Gap: An Anion Gap of 52 Fully Explained
Uma Mahesh R. Avula, Liliia Harris, Tariq Shafi, Neville R. Dossabhoy. The
University of Mississippi Medical Center, Jackson, MS.
Introduction: The Anion Gap (AG) remains the main clinical tool to elucidate acidbase disturbances in patients with metabolic acidosis. We present a case with an extremely
elevated AG of 52 mmol/L, and describe our search for its biochemical explanation.
Case Description: A 66-year-old female was admitted with loss of consciousness,
shock, and severe acute kidney injury. She had type 2 diabetes mellitus, treated
with metformin. At presentation, she had an AG of 52 mmol/L and osmolal gap of

Is an Increase in Anion Gap a Predictor of Hemodialysis Initiation in
Patients with Advanced CKD?
Hikaru Kukimoto, Kazuhito Fukuoka, Soko Kawashima, Noriko Ikegaya,
Takahisa Kawakami, Mitsumasa Kishimoto, Yoshinori Komagata,
Shinya Kaname. Kyorin Daigaku, Mitaka, Japan.
Background: Because uremic symptoms and manifestations vary among patients
with advanced chronic kidney disease, it is sometimes difficult to decide on the timing of
dialysis initiation only from them. Thus, we attempted to investigate whether anion gap
(AG) that may reflect the accumulation of total organic acids in uremia can be a marker of
uremia and may predict the timing of dialysis initiation.
Methods: This study included pre-dialysis patients who attended to our hospital for
more than six months prior to the beginning of hemodialysis (HD), and retrospectively
analyzed the relationship between their serological data, AG, and various uremic
symptoms. The AG was calculated as the corrected AG (cAG) = Na-Cl-HCO3
[nmol/L]+2.5 x (4-serum albumin concentration [g/L]). The statistical analysis was
performed by logistic regression analysis, correlation analysis, and factor analysis using
SPSS®.
Results: A total of 283 patients [diabetes mellitus: 136 (48.1%), nephrosclerosis:
66 (23.3%), glomerulonephritis: 36 (12.7%)] were included in this study. The most
common clinical symptom before dialysis initiation was fluid overload, which was seen in
134 patients (47.3%), followed by anorexia 104 patients (36.7%) and general malaise
96 patients (33.9%). The cAG began to increase 3 months before the initiation of HD
(14.2 mmo/L), which showed a rapid increase just before the initiation, and was correlated
with anorexia and fatigue, better than fluid retention. Of note is that cAG was most
significantly associated with dialysis initiation among various factors. The ROC of cAG
for dialysis initiation showed the highest value of AUC 0.797 (95% CI=0.72 to 0.85,
p=0.05), with a cutoff value of adjusted cAG 15.975 (sensitivity 0.689, specificity 0.786).
Conclusions: Uremic symptoms and some serological markers including azotemia,
metabolic acidosis, and hyperphosphatemia have been usually used to predict the
magnitude of uremia and the timing of dialysis initiation. In our study, it is suggested that
a rapid increase in cAG over 16 mEq/L may also be a good predictor of dialysis initiation
within the subsequent 3 months.
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Mysterious Case of Recurrent Life-Threatening Lactic Acidosis
Zakir Shaik, Waqas Ahmad Khan, Ajay D. Rao, Jean Lee. Temple University
Hospital Temple University Health System Inc, Philadelphia, PA.
Introduction: Patients living with diabetes are prone to type-B lactic acidosis, often
presenting with profound acid-base derangements. The reason for lactate production is
not obvious hence management can be challenging. We present a case of life-threatening
recurrent lactic acidosis in a diabetic patient.
Case Description: A 67-year-old man with type 2 diabetes, hypertension, presented
to the hospital with malaise for 2 days. He had been on metformin in the past but had
recently switched to insulin. There was no history of alcohol ingestion nor use of herbal
supplements. The lactic acid level was 24.2 mmol/L with Ph of 6.82, PCO2 of 27 mmHg,
serum bicarb of 7 mEq/L, anion gap of 28, and serum Cr of 1.4 mg/dL with baseline of
1 mg/dL. No evidence of infection or ischemia found. Toxicology screen was negative
and serum metformin level was undetectable. Lactic acidosis resolved with continuous
renal replacement (CRRT) for 24 hours. A month later he returned with similar complaints
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